More Investment in Europe After the Kink in the Curve
The corona pandemic has, of course, also presented pharmaceutical companies and plant manufacturers with unexpected challenges. In the medium and long term, however, the industry in Europe could benefit from the crisis.
In an interview with the specialist magazine Chemie Technik, Wolfram Gstrein talks about the impact of the corona crisis on VTU and new opportunities for the future in European pharmaceutical plant engineering.
As early as March we carried out the first risk assessments of the corona crisis for our business and developed various scenarios. We saw more opportunities than risks for our company, which is why we decided to make further investments.